NONSTEROIDAL ANTIINFLAMMATORY DRUGS OF PLANT ORIGIN IN THE TREATMENT OF NONSPECIFIC CHRONIC BACK PAIN


Дәйексөз келтіру

Толық мәтін

Аннотация

The article presents the results of evaluation of effectiveness and safety of Zinaxin, nonsteroidal antiinflammatory drug (NSAID) of plant origin (containing two specially selected ginger extracts), in 20 patients with acute exacerbation of chronic lumbosacral pain syndrome. Against the background of Zinaxin use, pain intensity significantly decreased during the first and subsequent months: in addition, Zinaxin was well tolerated in long-term use by the patients. The drug can be recommended for patients with chronic nonspecific back pain as an alternative or additional preparation to traditional NSAIDs.

Авторлар туралы

Yuliya Azimova

Gyuzel' Tabeeva

Yu Azimova

G Tabeeva

Әдебиет тізімі

  1. Вознесенская Т.Г. Боли в спине и конечностях. В кн. Болевые синдромы в неврологической практике / Под редакцией А.М. Вейн и др. М., 1999. С. 217-84.
  2. Вознесенская Т.Г. Боли в спине: взгляд невролога // Consilium medicum. 2006. № 8. С. 28-32.
  3. Дроздов В.Н. Зинаксин - новый безопасный препарат для лечения остеоартрита // РМЖ. 2008. № 1. С. 1-3.
  4. Зырянов С.К., Нельга О.Н., Белоусов Ю.Б. Терапия боли: как снизить риск развития неблагоприятных побочных реакций // Справочник поликлинического врача. 2007. № 7. С. 14-6.
  5. Кукушкин М.Л. Патофизиологические механизмы болевых синдромов // Боль. 2003. № 1. С. 5-12.
  6. Неспецифическая боль в нижней части спины. Диагностика, лечение, предупреждение. М., 2008. С. 70.
  7. Парфенов В.А. Диагноз и лечение при болях в спине // РМЖ. 2004. № 12. С. 115-18.
  8. Подчуфарова Е.В. Боль в пояснично-крестцовой области: диагностика, лечение // РМЖ. 2006. № 2. С. 12-9.
  9. Подчуфарова Е.В. Боль в спине: доказательная медицина и клиническая практика // Трудный пациент. 2010. № 3 С. 14-21.
  10. Подчуфарова Е.В., Яхно Н.Н. Боль в спине. М., 2010. С. 368.
  11. Подчуфарова Е.В., Яхно Н.Н., Алексеев В.В. и др. Хронические болевые синдромы пояснично-крестцовой локализации: значение структурных скелетно-мышечных расстройств и психологических факторов // Боль. 2003. № 1. С. 38-43.
  12. Попелянский Я.Ю. Ортопедическая неврология. Казань, 1997. Т. 2. С. 487.
  13. Табеева Г.Р. Нурофен в лечении нейрогенных болевых синдромов // Consilium-medicum. 2006. № 3. С. 32-7.
  14. Тревелл Д.Г., Симонс Д.Г. Миофасциальные боли. М., 1989. Т. 1-2.
  15. Хабиров Ф.А. Клиническая неврология позвоночника. Казань, 2002. С. 472.
  16. Ших Е.В., Еременко Н.Н. Препараты природного происхождения как альтернативный путь терапии болевого синдрома в ревматологии // Вопросы современной педиатрии. 2008. № 1. С. 64-66.
  17. Якименко Е.А., Закатова Л.В., Кравчук О.Е. и др. Изучение эффективности и безопасности применения зинаксина в комплексной терапии больных остеоартрозом // Украинский терапевтический журнал. 2005. № 1. С. 64-7.
  18. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 2001;44:2531-38.
  19. Bandell M, Story GM, Hwang SW, et al. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004;41:849-57.
  20. Black CD, Herring MP, Hurley DJ, et al. Ginger (Zingiber officinale) Reduces Muscle Pain Caused by Eccentric Exercise. J Pain 2010. in print.
  21. Burke JG, Watson RW, McCormack D, et al. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 2002;84:196-201.
  22. Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American pain society. American college of physicians clinical practice guideline. Ann Intern Med 2007;147:505-14.
  23. Chrubasik JE, Roufogalis BD, Chrubasik S. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytother Res 2007;21:675-83.
  24. De Weck AL, Sanz ML, Gamboa PM, et al. Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis. J Investig Allergol Clin Immunol 2009;19:355-69.
  25. Frondosa CG, Sohrabi A, Polotsky A, et al. An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures. In Vitro Cell. Dev Biol Animal 2004;40:95-101.
  26. Haroutiunian S, Drennan DA, Lipman AG. Topical NSAID therapy for musculoskeletal pain. Pain Medicine 2010;11:535-49.
  27. Heavner JE, Bosscher HA, Wachtel MS. Cell types obtained from the epidural space of patients with low back pain/radiculopathy. Pain Pract 2009;9:167-72.
  28. Kanodia AK, Legedza AT, Davis RB, et al. Perceived benefit of Complementary and Alternative Medicine (CAM) for back pain: a national survey. J Am Board Fam Med 2010;23:354-62.
  29. Kim SO, Chun KS, Kundu JK, et al. Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin. Biofactors 2004;21:27-31.
  30. Kiuchi F, Iwakami S, Shibuya M, et al. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull 1992;40:387-91.
  31. Langevin HM, Stevens-Tuttle D, Fox JR, et al. Ultrasound evidence of altered lumbar connective tissue structure in human subjects with chronic low back pain. BMC Musculoskelet Disord 2009;3:151.
  32. Lindmark L, Sohrabi A, Phan PV, et al. Modulation of pro-inflammatory mediator and metalloproteinase expression in human synoviocytes. Materials of 5th symposium of ICRS 2004;93-7.
  33. Lindsley HB, Smith DD, Cohic CB, et al. Proinflommatory cytokines enchance human synoviocyte expression of functional intercellular adhesion molecule-1 (ICAM-1). Clin Immunol Immunopathol 1993;68:331-20.
  34. Machado LAC, Kamper SJ, Herbert RD, et al. Analgesic effects of treatments for non-specific low back pain: a meta-analysis of placebo-controlled randomized trials. Rheumatology 2009;48:520-7.
  35. Nurtjahja-Tjendraputra E, Ammit AJ, et al. Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thromb Res 2003;111:259-65.
  36. Ohtori S, Inoue G, Ito T, et al. Tumor necrosis factor-immunoreactive cells and PGP 9.5-immunoreactive nerve fibers in vertebral endplates of patient with discogenic low back pain and modic type 1 or type 2 changes on MRI. Spine 2006;31:1026-31.
  37. Omoigui S. The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3 - inflammatory profile of pain syndromes. Med Hypotheses 2007;69:1169-78.
  38. Phan PV, Sohrabi A, et al. Ginger extract components suppress induction of chemokine expression in human synoviocytes. J Alt Comp Med 2005;11:149-54.
  39. Rannou F, Ouanes W, Boutron I, et al. High-sensitivity C-reactive protein in chronic low back pain with vertebral end-plate Modic signal changes. Arthritis Rheum 2007;57:1311-15.
  40. Roelofs PD, Deyo RA, Koes BW, et al. Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review. Spine 2008;33:1766-74.
  41. Roumie CL, Arbogast PG, Mitchel EF Jr, et al. Prescriptions for chronic high-dose cyclooxygenase-2 inhibitors are often inappropriate and potentially dangerous. J Gen Intern Med 2005;20:879-83.
  42. Seybold VS, Jia YP, Abrahams LG. Cyclo-oxygenase-2 contributes to central sensitization in rats with peripheral inflammation. Pain 2003;105:47-55.
  43. Shikh E. Open comparative study in patients with osteoarthritis of the knee I-III stages: all patients with NSAIDs intolerance.
  44. Shimoda H, Shan SJ, Tanaka J, et al. Anti-inflammatory properties of red ginger (Zingiber officinale var. Rubra) extract and suppression of nitric oxide production by its constituents. J Med Food 2010;13:156-62.
  45. Sieper J, van der Heijde D, Landewé R, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 2009;68:784-88.
  46. Tjendraputra E, Tran VH, Liu-Brennan D, et al. Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg Chem 2001;29:156-63.
  47. Wells RE, Phillips RS, Schachter SC, et al. Complementary and alternative medicine use among US adults with common neurological conditions. J Neurol 2010. in print.
  48. Wu H, Ye DJ, Zhao YZ, et al. Effect of different preparations of ginger on blood coagulation time in mice. Zhongguo Zhon Yao Za Zhi 1993;18:147-49.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>